Life science solutions and consulting
An introduction to Lakeside Pharma
Welcome to Lakeside Pharma Limited, founded by Dr. Dev Kumar, dedicated to providing the Life Sciences industry with comprehensive solutions spanning market access, commercialization, regulatory compliance, due diligence, legal advisories, and IP projects.
Our services range from one-time consultations and business viability studies to longer-term engagements. Leveraging an extensive network of partners, we offer a complete suite of pharmaceutical services, from IP generation and clinical trials to successful commercial launches and ongoing support, ensuring your success at every stage of development and beyond.
Our Experience
From Strategic Acquisitions to Global Partnerships and High-Value Exits. Lakeside Pharma's journey includes acquiring critical care portfolios, securing global rights to innovative medications, forming key partnerships, and achieving a €750M acquisition by Recordati. With a focus on specialty care and rapid asset launches, Lakeside Pharma has become a leading force in the life sciences industry, driving commercial success across the globe.
-
Item descriptionSpecialty Care business worth £500m in UK and 150 people.19 assets and 100 indications.
Serial launches across the UK/Ireland.
-
Acquired critical care portfolio from Jazz Pharma in 2015
Acquired ex-US rights to FOTIVDA® from AVEO Oncology.
Acquired global rights to QARZIBA® from Apeiron Biologics.
Divested critical care portfolio
Acquired global rights to SYLVANT® from J&J.
High-value partnership with BeiGene in China for QARZIBA® & SYLVANT®.
Exit in March 2022 with €750M acquisition by Recordati.
-
20 country Asian portfolio with fastest growing territory globally.
Management or affiliate and partners, POM and OTC.
Fastest launch assets in Organisation.
-
Over 20 companies from OTC to POM across the Globe driving commercial success.
Executive Team
-
Dev Kumar | CEO and CMO
Dr. Dev Kumar MD, JD and NED.
Former gynaecologist.
EUSA Pharma: GC and CoSec.
Leadership, Legal, Commercial, M&A, Regulatory & IP Roles.
BI, Biogen, and UCB.
-
Ewan McDowall | CCO
Strategic Consultant for market entry globally and commercial excellence for pharmaceuticals, medical devices and FMCG.
Ipsen: Head of Asia; VP Speciality Care & VP Commercial Ops.
Pfizer: Head of Speciality Care.
SmithKline Beecham and Eli Lilly.
Senior Management Team
-
Medical Adviser
Consultant at the Portland and UCLH / former MRC Research Fellow
-
Head of Marketing
Over 23 years’ experience in digital marketing & PR including Healthcare
-
Head of Sales:
Over 25 years in Blue Chip Pharma Sales and Marketing
Summary
Lakeside Pharma offer a range of services to the life science industry; including market access, commercialisation, regulatory, IP, clinical development and legal support with both one time and long term consulting services.
Proven leadership team (in pharmaceuticals, medical devices and OTC products) that have taken multiple assets to market globally with proven revenue demonstration.
Able to leverage experience of prescription medicines (biologics through to small molecules), OTC products and medical devices / technology, to address client requirement
Contact Us
Get in touch with Lakeside Pharma Limited today to explore how our comprehensive pharmaceutical solutions can drive success for your projects.